Pixee Medical announced the first U.S. procedure using the FDA-cleared Kneeᐩ NexSight system for total knee arthroplasty.
Following this successful completion of the first U.S. procedure, Pixee Medical is focused on expanding the use of Kneeᐩ NexSight across Ambulatory Surgical Centers throughout the United States.
Unlike traditional robotic systems that require infrastructure and extra personnel, Kneeᐩ NexSight is implant-agnostic, was designed with insights from U.S. surgeons, and built upon proven technology with more than 10,000 successful cases worldwide. The augmented reality (AR) system integrates into existing workflows, requires no pre-op CT scans and achieves implant positioning with robotic-like precision. The wearable headset equips surgeons with real-time AR guidance while eliminating physical disposables to minimize environmental impact and decrease operating costs. Because the technology is compact and agile, it’s ideal for use in Ambulatory Surgical Centers.
“This isn’t just an upgrade, it’s a rethink,” said Sébastien Henry, founder and CEO of Pixee Medical. “Kneeᐩ NexSight is designed to meet the demands of the U.S. market: high-volume, cost pressures, and surgical autonomy. AR navigation lets us bring advanced guidance to more surgeons, in more settings, without the compromises of older technology. By enabling more personalized and precise implant placement, unique to a patient’s anatomy, Kneeᐩ NexSight helps to optimize patient outcomes.”
Pixee Medical announced the first U.S. procedure using the FDA-cleared Kneeᐩ NexSight system for total knee arthroplasty.
Following this successful completion of the first U.S. procedure, Pixee Medical is focused on expanding the use of Kneeᐩ NexSight across Ambulatory Surgical Centers throughout the United States.
Unlike traditional...
Pixee Medical announced the first U.S. procedure using the FDA-cleared Kneeᐩ NexSight system for total knee arthroplasty.
Following this successful completion of the first U.S. procedure, Pixee Medical is focused on expanding the use of Kneeᐩ NexSight across Ambulatory Surgical Centers throughout the United States.
Unlike traditional robotic systems that require infrastructure and extra personnel, Kneeᐩ NexSight is implant-agnostic, was designed with insights from U.S. surgeons, and built upon proven technology with more than 10,000 successful cases worldwide. The augmented reality (AR) system integrates into existing workflows, requires no pre-op CT scans and achieves implant positioning with robotic-like precision. The wearable headset equips surgeons with real-time AR guidance while eliminating physical disposables to minimize environmental impact and decrease operating costs. Because the technology is compact and agile, it’s ideal for use in Ambulatory Surgical Centers.
“This isn’t just an upgrade, it’s a rethink,” said Sébastien Henry, founder and CEO of Pixee Medical. “Kneeᐩ NexSight is designed to meet the demands of the U.S. market: high-volume, cost pressures, and surgical autonomy. AR navigation lets us bring advanced guidance to more surgeons, in more settings, without the compromises of older technology. By enabling more personalized and precise implant placement, unique to a patient’s anatomy, Kneeᐩ NexSight helps to optimize patient outcomes.”
Copy to clipboard 
